MASI Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

407.59M

-32.15%

1.460

-18.89%

398.21M

+7.04%

1.421

+4.52%

398.44M

+7.43%

1.380

+3.76%

Estimates Revision

The market is revising Upward the revenue expectations for Masimo Corporation (MASI) for FY2025, with the revenue forecasts being adjusted by 0.01% over the past three months. During the same period, the stock price has changed by -7.71%.

Revenue Estimates for FY2025

Revise Upward

+0.01%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+2.77%

In Past 3 Month

Stock Price

Go Down

-7.71%

In Past 3 Month

4 Analyst Rating

Wall Street analysts forecast MASI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MASI is 161.00 USD with a low forecast of 105.00 USD and a high forecast of 198.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

105.00

Averages

161.00

High

198.00

Current: 0.000

Low

105.00

Averages

161.00

High

198.00

Wells Fargo

Overweight

maintain

$187 -> $190

2025-12-05

Reason

Wells Fargo

Price Target

$187 -> $190

2025-12-05

maintain

Overweight

Reason

Wells Fargo raised the firm's price target on Masimo to $190 from $187 and keeps an Overweight rating on the shares. The firm says the company's Investor Day highlighted confidence in multi-year growth trajectory. Wells also notes that 7%-10% revenue CAGR through 2028, with new products is expected to drive double digits growth post-2028.

BTIG

Buy

maintain

$198 -> $200

2025-12-04

Reason

BTIG

Price Target

$198 -> $200

2025-12-04

maintain

Buy

Reason

BTIG raised the firm's price target on Masimo to $200 from $198 and keeps a Buy rating on the shares after the company's Investor Day presentation. The firm is positive on the company's potential to be one of the most consistent performers in MedTech over the coming years, the analyst tells investors in a research note. BTIG adds that it likes that the company will continue to invest in next-gen sensors and monitors in a market that has seen minimal product innovation from competitors and believes it will allow the company to achieve sustainable high single digit growth during and beyond the Long Range Plan.

BofA

Neutral

initiated

$162

2025-11-17

Reason

BofA

Price Target

$162

2025-11-17

initiated

Neutral

Reason

BofA initiated coverage of Masimo with a Neutral rating and $162 price target.

Piper Sandler

Jason Bednar

Overweight

maintain

$200 -> $210

2025-08-06

Reason

Piper Sandler

Jason Bednar

Price Target

$200 -> $210

2025-08-06

maintain

Overweight

Reason

Piper Sandler analyst Jason Bednar raised the firm's price target on Masimo to $210 from $200 and keeps an Overweight rating on the shares. The firm notes the company announced Q2 revenue of $370M/+7% cc in line with Street's $369M, a minor victory considering perceived risk tied to the cybersecurity incident that negatively affected order fulfillment during May. The only question being circulated ties to incremental contracting being down year-over-year, but Piper finds it hard to give this too much negative weight when considering contract backlog still expanded nicely year-over-year.

BTIG

Buy

maintain

$183 -> $198

2025-07-14

Reason

BTIG

Price Target

$183 -> $198

2025-07-14

maintain

Buy

Reason

BTIG raised the firm's price target on Masimo to $198 from $183 and keeps a Buy rating on the shares as part of a broader research note previewing Q2 results in MedTech. Healthcare was a laggard in Q2 relative to the S&P, and early into Q3, MedTech is underperforming as fears of Medicaid cuts and hospital closures weigh on the sector following recent legislation, the analyst tells investors in a research note. The fears are likely overblown, though the earnings season is likely to offer a mixed picture as sentiment is extremely binary right now, with some companies pushing extreme valuations and others "left for dead", BTIG notes. The firm adds however that on one hand, inflation is calm, markets are at highs, and Fx has turned demonstrably favorable.

Needham

Mike Matson

Hold

Reiterates

n/a

2025-04-10

Reason

Needham

Mike Matson

Price Target

n/a

2025-04-10

Reiterates

Hold

Reason

Valuation Metrics

The current forward P/E ratio for Masimo Corp (MASI.O) is 22.26, compared to its 5-year average forward P/E of 39.47. For a more detailed relative valuation and DCF analysis to assess Masimo Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

39.47

Current PE

22.26

Overvalued PE

53.40

Undervalued PE

25.53

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

23.45

Current EV/EBITDA

14.85

Overvalued EV/EBITDA

32.34

Undervalued EV/EBITDA

14.56

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

5.39

Current PS

4.27

Overvalued PS

8.51

Undervalued PS

2.26

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

MASI News & Events

Events Timeline

No data

News

1.0

01-07Yahoo Finance

Masimo to Participate in J.P. Morgan 2026 Healthcare Conference

8.5

01-04Benzinga

SoftBank to Acquire DigitalBridge for $4 Billion, Expanding AI Infrastructure

5.0

01-04Benzinga

Apple Cuts Vision Pro Production and Significantly Reduces Advertising Spend

People Also Watch

Frequently Asked Questions

What is Masimo Corp (MASI) stock price today?

The current price of MASI is 138.92 USD — it has increased 0.73 % in the last trading day.

What is Masimo Corp (MASI)'s business?

Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.

What is the price predicton of MASI Stock?

What is Masimo Corp (MASI)'s revenue for the last quarter?

Masimo Corp revenue for the last quarter amounts to 371.50M USD, increased 8.21 % YoY.

What is Masimo Corp (MASI)'s earnings per share (EPS) for the last quarter?

Masimo Corp. EPS for the last quarter amounts to -1.86 USD, decreased -1133.33 % YoY.

What changes have occurred in the market's expectations for Masimo Corp (MASI)'s fundamentals?

How many employees does Masimo Corp (MASI). have?

Masimo Corp (MASI) has 3600 emplpoyees as of January 10 2026.

What is Masimo Corp (MASI) market cap?

Today MASI has the market capitalization of 7.46B USD.